Karvy Stock Broking has recommended market performer rating on Ranbaxy Laboratories with a target of Rs 600, in its September 22, 2010 research report.
“Ranbaxy Labs will have sole exclusive rights in US for selling Aircept's generic version which is used in the treatment for Alzheimer's. We confirmed the same with the management. Ranbaxy has reiterated its stand on the ability to monetize all its FTF (first to file) opportunities. “
For more stock tips and ideas visit STOCKINDIA.SLINKSET.COM NOW.
From: http://www.moneycontrol.com/news/recommendations/ranbaxy-labsmarket-performer-karvy_486402.html
GET FREE SENSEX & NSE TIPS IN YOUR MOBILE PHONE:
NOW GET THIS SITE'S FREE TIPS OF SENSEX AND NIFTY IN YOUR MOBILE PHONE WITHOUT PAYING A SINGLE PAISA.
CLICK TO SUBSCRIBE "SENSEXNSE TIPS" FOR FREE
Subscribe to:
Post Comments (Atom)
SEARCH THIS SITE FOR MORE TIPS AND STOCK NEWS
Computers @ RS.11,000
Games 4 U
EARN FROM SMS
50% DISCOUNT MOVIES
Nokia Mobile
EARN 4 NETWORKING
BOOKS @ HALF-RATE
**UN-BELIEVABLE DEALS**
PERSONAL CARE @ RS.100
Cheapest Camera @ Rs.2800
MOBILES FOR RS.800
LCD TV & VIDEO @ RS.1400
EMAIL 4 CASH
START OWN YOUTUBE @ 20$
BUILD OWN APPS
Hot Photos 4 u
HOT MOOD VIDEOS
Lijit Search
LATEST NSE TIPS FOR ALL :
No comments:
Post a Comment